Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies
US-9527914-B2 · Dec 27, 2016 · US
against hormone receptors (for antibodies against neuromediator receptors C07K16/286)
against hormone receptors (for antibodies against neuromediator receptors C07K16/286) · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/2869 |
| Official title | {against hormone receptors (for antibodies against neuromediator receptors C07K16/286)} |
| Display label | against hormone receptors (for antibodies against neuromediator receptors C07K16/286) |
| Total patents | 623 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 38 |
| 2016 | 47 |
| 2017 | 56 |
| 2018 | 59 |
| 2019 | 66 |
| 2020 | 46 |
| 2021 | 76 |
| 2022 | 72 |
| 2023 | 42 |
| 2024 | 49 |
| 2025 | 63 |
| 2026 | 9 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Methods and compositions for treating solid tumors and enhancing tumor vaccines
US-2016368996-A1 · Dec 22, 2016 · US
Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
US-9512236-B2 · Dec 6, 2016 · US
Methods and Monitoring of Treatment With A WNT Pathway Inhibitor
US-2016346388-A1 · Dec 1, 2016 · US
Therapeutic and diagnostic methods for autism spectrum disorders and other conditions
US-2016334413-A1 · Nov 17, 2016 · US
Targeted human-interferon fusion proteins
US-9492562-B2 · Nov 15, 2016 · US
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
US-2016319028-A1 · Nov 3, 2016 · US
Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs
US-9474794-B2 · Oct 25, 2016 · US
Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II)
US-9458239-B2 · Oct 4, 2016 · US
Antibody locker for the inactivation of protein drug
US-2016185875-A1 · Jun 30, 2016 · US
Cell culture improvements
US-2016186130-A1 · Jun 30, 2016 · US
Antibodies for guanylyl cyclase receptors
US-2016168251-A1 · Jun 16, 2016 · US
Compositions and methods related to structures that cross the blood brain barrier
US-2016152719-A1 · Jun 2, 2016 · US
Targeted Modified IL-1 Family Members
US-2016152730-A1 · Jun 2, 2016 · US
Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
US-9353186-B2 · May 31, 2016 · US
Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies
US-2016137738-A1 · May 19, 2016 · US
ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY
US-2016108124-A1 · Apr 21, 2016 · US
Anti-PRLR antibodies and methods for killing PRLR-expressing cells
US-9302015-B2 · Apr 5, 2016 · US
Methods of producing adalimumab
US-9284371-B2 · Mar 15, 2016 · US
Molecular targets and compounds, and methods to identify the same, useful in the treatment of fibrotic diseases
US-2016054304-A1 · Feb 25, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/2869?
- CPC C07K16/2869 is the Cooperative Patent Classification code for “against hormone receptors (for antibodies against neuromediator receptors C07K16/286).”
- How many patents are filed under CPC C07K16/2869 (against hormone receptors (for antibodies against neuromediator receptors C07K16/286))?
- Our database includes 623 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/2869 growing?
- Publication counts under this code: 49 in 2024 vs 63 in 2025 (latest complete years).